NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression
NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression GlobeNewswire December 16, 2025 TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, […]